Compliance with taking imatinib mesylate in patients with chronic myeloid leukemia in the chronic phase.
Toru
T
Kiguchi
Tetsuzo
T
Tauchi
Yoshikazu
Y
Ito
Keisuke
K
Miyazawa
Yukihiko
Y
Kimura
Kazuma
K
Ohyashiki
D001549:Benzamides; D006801:Humans; D000068877:Imatinib Mesylate; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000188:drug therapy*; D015466:Leukemia, Myeloid, Chronic-Phase / Q000188:drug therapy; D010349:Patient Compliance / Q000706:statistics & numerical data*; D010879:Piperazines / Q000627:therapeutic use*; D011743:Pyrimidines / Q000627:therapeutic use*
D001549:Benzamides; D010879:Piperazines; D011743:Pyrimidines; D000068877:Imatinib Mesylate